In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...

During Donald Trump's draconian first-week rollbacks, cancer research and other crucial medical projects have been paused ...

In a bombshell announcement made last week, the Food and Drug Administration (FDA) said it will ban the use of FD&C Red No. 3 ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...

The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...

A groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...

Studies going back decades have shown a potential link between artificial food dyes and attention deficit hyperactivity ...